Vilkin A - Search Results

1

[Surveillance of patients with inflammatory bowel diseases].

Moshkowitz M, Kariv R, Half B, Vilkin A, Levi Z, Niv Y, Dotan I; Section of Gastrointestinal Oncology of the Israeli Gastroenterological Association. Moshkowitz M, et al. Among authors: vilkin a. Harefuah. 2011 Apr;150(4):389-91, 417. Harefuah. 2011. PMID: 22164923 Hebrew.

2

[Surveillance of patients with gastric intestinal metaplasia and dysplasia].

Vilkin A, Half B, Moshkowitz M, Kariv R, Levi Z. Vilkin A, et al. Harefuah. 2011 Mar;150(3):266-8, 302. Harefuah. 2011. PMID: 21574363 Hebrew.

3

[Surveillance of patients after colonoscopic polypectomy and curative resection of colorectal cancer].

Niv Y, Half B, Moshkowitz M, Kariv R, Vilkin A, Levi Z. Niv Y, et al. Among authors: vilkin a. Harefuah. 2010 Oct;149(10):670-3, 682. Harefuah. 2010. PMID: 21568065 Hebrew.

4

[The Israeli recommendations for diagnosis, management, follow-up and prevention of colorectal cancer (CRC) in familial adenomatous polyposis].

Half E, Goldberg Y, Kariv R, Vilkin A, Levi Z, Moshkowitz M, Niv Y; Israeli Gastroenterology Association. Half E, et al. Among authors: vilkin a. Harefuah. 2011 Jul;150(7):603-6, 616, 615. Harefuah. 2011. PMID: 21874773 Hebrew.

5

[Guidelines for diagnosis, treatment, surveillance and prevention of cancer in patients with familial non-adenomatous polyposis].

Half E, Goldberg Y, Kariv R, Cohen-Ezra O, Vilkin A, Levi Z, Moshkowitz M, Niv Y; Israeli Gastroenterology Association. Half E, et al. Among authors: vilkin a. Harefuah. 2011 Jul;150(7):607-10, 615. Harefuah. 2011. PMID: 21874774 Hebrew.

6

[Management of hereditary non-polyposis syndrome (Lynch syndrome)].

Kariv R, Goldberg Y, Soler I, Rosner G, Half E, Moshkowitz M, Vilkin A, Levi Z, Niv Y. Kariv R, et al. Among authors: vilkin a. Harefuah. 2011 Apr;150(4):392-6, 416. Harefuah. 2011. PMID: 22164924 Hebrew.

7

[Surveillance of patients with Barrett's esophagus].

Levi Z, Vilkin A, Moshkowitz M, Kariv R, Half B, Niv Y. Levi Z, et al. Among authors: vilkin a. Harefuah. 2011 Feb;150(2):190-2, 202. Harefuah. 2011. PMID: 22164952 Hebrew.

8

Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Niv Y. Levi Z, et al. Among authors: vilkin a. Aliment Pharmacol Ther. 2006 Nov 15;24(10):1475-81. doi: 10.1111/j.1365-2036.2006.03152.x. Epub 2006 Oct 10. Aliment Pharmacol Ther. 2006. PMID: 17032281

9

Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?

Hazazi R, Rozen P, Leshno M, Levi Z, Samuel Z, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y. Hazazi R, et al. Among authors: vilkin a. Aliment Pharmacol Ther. 2010 Feb 15;31(4):523-33. doi: 10.1111/j.1365-2036.2009.04202.x. Epub 2009 Nov 19. Aliment Pharmacol Ther. 2010. PMID: 19925498

10

Predictors of specialized intestinal metaplasia in patients with an incidental irregular Z line.

Dickman R, Levi Z, Vilkin A, Zvidi I, Niv Y. Dickman R, et al. Among authors: vilkin a. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):135-8. doi: 10.1097/MEG.0b013e3283318f69. Eur J Gastroenterol Hepatol. 2010. PMID: 19907339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters